ALBANY, N.Y.--(BUSINESS WIRE)--Transparency Market Research has announced the release of a report, titled “Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”.
The market was estimated at US$2.2 billion in 2012, and is anticipated to reach US$7.5 billion by the end of 2019, expanding at a healthy CAGR of 19.3% between 2013 and 2019.
Browse Research Report: http://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html
The global market for hospital acquired disease testing is segmented in terms of infection types and geography.
On the basis of type of infection, the market is segmented into surgical site infection (SSI) testing, urinary tract infection (UTI) testing, pneumonia testing, methicillin-resistant staphylococcus aureus (MRSA) testing, blood stream infection (BSI) testing, and others including bone, GI, cardiovascular, and respiratory, etc. The hospital acquired UTI testing segment is the most prevalent among all the types of nosocomial infections and represents the biggest market share on the basis of revenue in the market for HAI testing.
The increased prevalence of healthcare associated infections (HAIs) in the geriatric population and the rising count of drug-resistant pathogens are amongst the prime factors that have raised the prevalence of hospital acquired diseases globally.
Geographically, the global market for hospital acquired disease testing is segmented into Europe, North America, Asia Pacific, and Rest of the World. North America led the market and is trailed by Europe owing to initiatives taken by governments for preventing and controlling nosocomial infections in these regions.
Nordion, Inc., Qiagen GmbH, Becton, Dickinson and Co., Meridian Bioscience, Inc., Gen-Probe, Inc., bioMerieux, Inc., Abbott Laboratories, Inc., and Life Technologies Corp., among others, are amongst the key players in the market.
Transparency Market Research (TMR) is a U.S. based market Intelligence Company driven by high-pedigree consultants and researchers. TMR leverages its Syndicated Research, Custom Research, and Market Consulting expertise to help businesses make accurate decisions. TMR’s exclusive blend of quantitative forecasting and trends analysis draws on proprietary data sources and techniques, while their data repository is continuously updated to reflect the latest trends.